Carfilzomib (K) in Relapsed and Refractory Multiple Myeloma...

Clinical Lymphoma Myeloma and Leukemia 2019 / 09 Vol. 19

Carfilzomib (K) in Relapsed and Refractory Multiple Myeloma (RRMM): Frailty Subgroup Analysis from Phase 3 ASPIRE and ENDEAVOR

Facon, Thierry, Niesvizky, Ruben, Weisel, Katja, Bringhen, Sara, Ho, P. Joy, Obreja, Mihaela, Yang, Zhao, Klippel, Zandra, Blaedel, Julie, Mezzi, Khalid, Siegel, David
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.07.299
Date:
September, 2019
File:
PDF, 67 KB
english, 2019
Conversion to is in progress
Conversion to is failed